- Active not recruitingPHASE1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With Asthma
This study is looking into a new medication called APG777 for adults with mild to moderate asthma. It's a first step to see if it's safe and how the body handles it, compared to a dummy drug (placebo).
For: AsthmaUnited States · United Kingdom - Active not recruitingPHASE1
An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis
This study is looking at how safe and effective two new medicines (APG777 + APG990) are when used together for moderate to severe eczema, compared to an existing treatment (dupilumab).
For: Atopic DermatitisAustralia · Canada · New Zealand - RecruitingPHASE2
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
This study looks at a new medicine, APG777, for moderate-to-severe eczema (atopic dermatitis). It's for people who were in an earlier APG777 study and found the treatment helpful, to see if it's safe and works well over a longer time.
For: Atopic DermatitisUnited States · Canada · Germany - Active not recruitingPHASE2
A Study Evaluating APG777 in Atopic Dermatitis
This study is looking at a new medicine called APG777 for moderate to severe eczema (atopic dermatitis). Researchers want to see if it's safe and helps improve symptoms compared to a dummy medicine. It involves testing different strengths of APG777.
For: Atopic DermatitisUnited States · Canada · Czechia